1. Special Issue On the 2022 WHO Classification of Endocrine and Neuroendocrine Tumors: a New Primer for Endocrine Pathology Practice

   • Ozgur Mete

   EditorialNotes 04 March 2022 Pages: 1 - 2

2. From Counting Mitoses to Ki67 Assessment: Technical Pitfalls in the New WHO Classification of Endocrine and Neuroendocrine Tumors

   • Ian A. Cree

   Letter 13 January 2022 Pages: 3 - 5

   

3. Overview of the 2022 WHO Classification of Pituitary Tumors

   • Sylvia L. Asa
   • Ozgur Mete
   • Robert Y. Osamura

   ReviewPaper 15 March 2022 Pages: 6 - 26

   

4. Overview of the 2022 WHO Classification of Thyroid Neoplasms

   • Zubair W. Baloch
   • Sylvia L. Asa
   • Ozgur Mete

   ReviewPaper 14 March 2022 Pages: 27 - 63

   

5. Overview of the 2022 WHO Classification of Parathyroid Tumors

   • Lori A. Erickson
   • Ozgur Mete
   • Anthony J. Gill

   ReviewPaper 17 February 2022 Pages: 64 - 89

   

6. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas

   • Ozgur Mete
   • Sylvia L. Asa
   • Arthur Tischler

   ReviewPaper 13 March 2022 Pages: 90 - 114

   

7. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms

   • Guido Rindi
   • Ozgur Mete
   • Sylvia L. Asa

   ReviewPaper 16 March 2022 Pages: 115 - 154

   

8. Overview of the 2022 WHO Classification of Adrenal Cortical Tumors

   • Ozgur Mete
   • Lori A. Erickson
   • Mauro G. Papotti

   ReviewPaper 14 March 2022 Pages: 155 - 196

   

9. Overview of the 2022 WHO Classification of Familial Endocrine Tumor Syndromes

   • Vania Nosé
   • Anthony Gill
   • Lori Erickson

   ReviewPaper 13 March 2022 Pages: 197 - 227

   

10. The Next Steps for Endocrine Pathology

    • Sylvia L. Asa
    • Lori A. Erickson
    • Ozgur Mete

    EditorialNotes 28 February 2022 Pages: 228 - 230